SilkTech Biopharmaceuticals
Biotechnology ResearchMinnesota, United States2-10 Employees
SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Our lead indication is in Dry Eye Disease, an inflammatory based chronic condition.
SilkTech Biopharmaceuticals uses 8 technology products and services including Google Cloud CDN, RSS, Sirvoy, and more. Explore SilkTech Biopharmaceuticals's tech stack below.
| SilkTech Biopharmaceuticals Email Formats | Percentage |
| FirstLast@silk-tech.com | 50% |
| FirstLast@silk-tech.com | 50% |
Biotechnology ResearchMinnesota, United States2-10 Employees
SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Our lead indication is in Dry Eye Disease, an inflammatory based chronic condition.
SilkTech Biopharmaceuticals has raised a total of $6.2M of funding over 2 rounds. Their latest funding round was raised on Apr 16, 2019 in the amount of $6.2M.
SilkTech Biopharmaceuticals's revenue is estimated to be in the range of $1M
SilkTech Biopharmaceuticals has raised a total of $6.2M of funding over 2 rounds. Their latest funding round was raised on Apr 16, 2019 in the amount of $6.2M.
SilkTech Biopharmaceuticals's revenue is estimated to be in the range of $1M